TECHNOLOGIES 2024
Technologies marked with an * will be presented orally.
Cardiovascular
- E2*
Novel Autotaxin Inhibitors
Dr Mathias Eymery, Dr Andrew McCarthy
- H5*
TRYPTO Therapeutics Develops a Novel Class of Tryptophan Hydroxylase-1 Inhibitors to Address Unmet Medical Needs in Serotonin-Dependent Diseases
Dr Edgar Specker, Dr Dirk Pleimes, Dr Radoslaw Wesolowski, Prof. Michael Bader
- H6
DeepNeo – Unlocking Effective Treatment for Vascular Healing
Valentin Koch, Dr Philipp Nicol
- S2
New Antithrombotic Drug
Prof. Lina Badimon, Dr Maria Borrell, Dr Teresa Padró
- U6
Method for the Diagnosis and Typing of Amyloidosis
Prof. Chiara Castellani, Prof. Annalisa Angelini, Marny Fedrigo, Prof. Gaetano Thiene, Prof. Maria Luisa Valente
Device
- B2
Monitoring and Puncturing System for Percutaneous Dilatational Tracheostomy with Improved Puncture Precision
Prof. Dirk Wilhelm, Dr Daniel Ostler-Mildner, Dr Roman Krumpholz, Dr Andreas Ranft
- F1
Protective Device for Subjects with Solitary Kidney or Kidney Disease
Dr Filippo Spreafico, Prof. Jose Felix Rodriguez Matas
- F3*
Vascular Simulation Device for Medical Training in Eco-guided Procedures
Dr Mirko Belliato, Prof. Michele Conti, Dr Francesca Dedola, Dr Erika Negrello
- F4*
Highly Personalized Non-Invasive Vagus Nerve Stimulation for the Treatment of Chronic Pain
Dr Angelica Carandina, Prof. Nicola Montano, Dr Costanza Scatà, Dr Riccardo Asnaghi, Prof. Eleonora Tobaldini, Dr Chiara Bellocchi
- S1
BRONCOPILLOW: A Cephalic Restraint Device for Bronchoscopy and other Medical Procedures
Marta Navarro, Laura Roca
- W3
Innovative Micro Free Flow Electrophoresis (microFFE) Chip
Dr Bernard Joris, Michaël Delmarcelle, Patrick Stefanic
Drug Delivery
- U5
A siRNA-Based Therapy for EEC Syndrome Associated Blindness
Prof. Mario Vincenzo Di Iorio
Gene & Cell Therapy, Gene Editing
- U5
A siRNA-Based Therapy for EEC Syndrome Associated Blindness
Prof. Mario Vincenzo Di Iorio
Immune/Autoimmune
- A7*
Novel Diagnostic for Liver Diseases
Dr Richard Taubert
- C1*
A Novel Small Molecule for Treatment of Non-Histaminergic and Chronic Itch
Prof. Achim Schmidtko, Prof. Eugen Proschak, Annika Balzulat, Wenxin Felix Zhu, Dr Victor Hernandex Olmos, Dr Jan Heering, Dr Cathrin Flauaus, Dr Ruirui Lu, Prof. Dieter Steinhilber
- H1*
TUBiRA: Lead Optimization of First-in-Class TRAF6-Ubc13 Inhibitors for Treatment of Rheumatoid Arthritis
Dr Kamyar Hadian, Dr Jara Brenke, Prof. Oliver Plettenburg, Dr Gerrit Jürjens, Paul Wienecke
- I2*
PX, a Selective, Alternative Pathway Inhibitor for Treatment of Complement Dysregulation Diseases
Dr Sebastian Zoll, Hagen Sülzen
- W1*
Single-Domain Antibody Inhibiting Neutrophil Elastase for the Treatment of Inflammatory Lung Diseases
Dr Mireille Dumoulin, Dr Francisco Javier Morales Yanez, Dr Paola Redeghieri, Dr Rita Vanbever, Dr Jessica Vanderstraeten, Dr Teresinha Leal, Dr Serge Muyldermans, Dr Cécile Vincke
Infection
- A1*
Overcoming Resistance - Novel Inhibitors of Virulence Factor LasB of Pseudomonas aeruginosa
Dr Jörg Haupenthal, Prof. Anna K. H. Hirsch, Prof. Rolf W. Hartmann, Dr Andreas Kany, Prof. Christian Ducho, Dr Katrin Voos
- A2*
Novel Inhibitors of Cytomegalovirus
Prof. Mark Brönstrup, Prof. Martin Messerle
- A4*
Efficient, Adjuvant-Free Mucosal Vaccination via IgA Feedback Loop
Dr Andreas Frey, Dr Barbara Frey, Dr Katrin Ramaker, Dr Niels Röckendorf
- B3*
New Antimicrobial Peptide against Antibiotic Resistant Bacteria
Dr Sigrid Bülow, Prof. André Gessner
- B4
Targeting NF-κB Signaling in the Fight against Viruses
Prof. Andreas Pichlmair, Vincent Grass, Anqi Wang
- E3*
Novel Drug Combinations to Fight Multi-Resistant Bacteria and Prevent Antibiotic Damage on the Gut Microbiome
Dr Athanasios Typas, Dr Elisabetta Cacace, Dr Stephan Göttig, Dr Lisa Maier, Dr Camille Goemans, Dr Ana Rita Gontao Brochado
- H3*
Novel Therapeutics to Tackle the STI Crisis (Focus: Neisseria gonorrhoeae)
Dr Katarina Cirnski, Dr Kamaleddin Tehrani, Prof. Rolf Müller, Dr Thomas Hesterkamp
- I4
Peptide Killers of Bacteria
Prof. Robert Vácha, Rahul Deb, Dr Ivo Kabelka
- M1*
A Novel Platform for Mucosally-Applied Vaccines Against Respiratory Viruses
Prof. Reinhard Fässler, Prof. Wolfgang Neubert, Dr Marian Wiegand, Prof. Ulrich Lauer
- W2*
New TMPRSS2 Inhibitors as Antivirals for Coronavirus and Influenza Pandemics
Dr Pierre Francotte, Dr Bernard Pirotte, Dr Chahrazade El Amri, Dr Michèle Reboud-Ravaux
Metabolism
- B1
Novel Clinical Biomarker for Hepatic Steatosis
Prof. James Hutchinson, Prof. Jens Werner, Dr Florian Bitterer
Neurology
- F5*
MicroRNAs as Diagnostic Biomarkers and Therapeutic Agents for Small Fiber Neuropathy
Dr Mirna Andelic, Prof. Giuseppe Lauria Pinter, Dr Stefania Marcuzzo, Dr Erika Salvi
- I1
Neuroactive Steroids for Neuropathic Pain Treatment
Dr Eva Kudova, Dr Jiri Palecek
- I6*
New Treatment for Glaucoma
Dr Pete Williams, Prof. Andrea Brancale
- P2*
Anti-KLK8 against Alzheimer’s disease
Prof. Kathy Keyvani, Dr Arne Herring
- U1
TREM2MEDS: TREM2 Microglia Engineering for Early Onset Dementia
Prof. Alessandra Biffi
- U3
Prognostic Survival Index in Glioblastoma Aased on Alterations in Cerebral White Matter Connections
Prof. Maurizio Corbetta, Dr Alessandro Salvalaggio, Dr Lorenzo Pini
Oncology
- A6
The CXCR3ALT-CXCL11 Chemokine System for Therapeutic Use in Solid Cancer
Dr Michael Schmück-Henneresse, Prof. Dieter Volk, Dr Timo Vollmer, Prof. Petra Reinke, Dr Stephan Schlickeiser
- A8*
Arming Oncolytic Viruses Using Membrane-Associated T-Cell Activators (MATEs)
Prof. Florian Kühnel, Dr Thomas Wirth, Malin Peter
- E5*
Method for ENO1-Based Compound Screening to Modulate Glycolysis in Cancer Cells
Prof. Matthias Hentze, Dr Ina Huppertz
- H2
Heidelberg Epignostix: AI-Based Software Tools for Precision Molecular Tumor Diagnosis
Dr David Jones, Prof. Stefan Pfister, Prof. Andreas von Deimling
- I3*
Chemically Engineered NK Cells for Cancer Immunotherapy
Dr Milan Vrabel, Dr Rastislav Dzijak, Dr Anna Kovalova, Simona Bellová
- M3*
Generation of an Antibody Directed Against CCL22 for Cancer Immunotherapy
Prof. Stefan Endres, Prof. David Anz, Dr Reimar Abraham
- S3
New Treatment for Fanconi Anemia Patients with HNSCC
Dr Jordi Surrallés
- S4
New Nanotargeting Therapy for Colorectal Cancer
Dr Ramon Mangues
- U2
Cu(I) Complexes as Novel AntitumoR AgEnts (CuRE)
Prof. Valentina Gandin, Prof. Cristina Marzano, Prof. Marina Porchia, Dr Francesco Tisato
- U3
Prognostic Survival Index in Glioblastoma Aased on Alterations in Cerebral White Matter Connections
Prof. Maurizio Corbetta, Dr Alessandro Salvalaggio, Dr Lorenzo Pini
- U4
1-Piperidinpropionic Acid for Tumor Treatment
Prof. Patrizia Pontisso, Alessandra Biasiolo, Dr Andrea Martini, Dr Santina Quarta, Mariagrazia Ruvoletto, Prof. Cristian Turato, Gianmarco Villano
Others
- C1*
A Novel Small Molecule for Treatment of Non-Histaminergic and Chronic Itch
Prof. Achim Schmidtko, Prof. Eugen Proschak, Annika Balzulat, Wenxin Felix Zhu, Dr Victor Hernandex Olmos, Dr Jan Heering, Dr Cathrin Flauaus, Dr Ruirui Lu, Prof. Dieter Steinhilber
- I7
Inhibitors of Rhomboid Intramembrane Proteases
Dr Kvido Strisovsky
- M2*
Inhibition of Alpha Kinase 1 (ALPK1) – Novel Treatment for Inflammatory, Cardiorenal and Rare Diseases
Prof. Thomas F Meyer, Dr Lennart Pfannkuch, Dr Bert Klebl
- P1*
Extracorporeal Apheresis to Treat Preeclampsia
Dr Henning Hagmann, Prof. Manuel Koch, Prof. Thomas Benzing, Prof. Bernhard Schermer, Mahsa Matin
- P3
Supplements for T Cell-Based Immunotherapy
Prof. Christian Kurts, Dr Ann-Kathrin Baumgart
- P4
Treatment of Ocular Hypertension
Prof. Holger Stark, Prof. Alessio Nocentini, Tobias Werner, Claudiu Trandafir Supuran, Markus Schultes, Flavia Iovane
Tools
- A3*
Biodynamers Enhance Drug Delivery
Prof. Sangeun Lee, Prof. Claus-Michael Lehr, Dr Brigitta Loretz, Prof. Anna Hirsch
- A5*
TCR/CD3-Specific CAR NK-92 Cells for Purification of TCR-Modified Cell Products
Dr Dimitrios Wagner, Jonas Kath, Dr Weijie Du
- E4
Comprehensive Modular Epigenome Editing Platform
Dr Jamie A. Hackett, Dr Cristina Policarpi
- E6
QSPeed: Validation of Quantitative Systems Pharmacology (QSP) Models
Dr Rahuman Sheriff Malik Sheriff, Dr Henning Hermjakob
- H4
BaoBab - a Platform for Broad Isolation and Characterization of Human Monoclonal Antibodies
Prof. Harald Prüß, Dr Eugenio Fava, Dr Dominik Stappert, Dr Jakob Kreye
- I5*
Coelenterazine-Utilizing Luciferase Reporters with Extremely Stable Glow-Type Bioluminescent Signal
Martin Toul, Dr Andrea Schenkmayerova, Dr Martin Marek, Dr Jose Gaspar Rangel Pamplona Pizarro Pinto, Dr Joan Planas Iglesias, Daniel Pluskal, Dr Michal Vašina, Dr David Bednář, Prof. Zbyněk Prokop, Prof. Jiří Damborský